par Salcedo, Margarita;Bercovici, Nadège;Taylor, Rachel;Vereecken, Pierre 
;Massicard, Séverine;Duriau, Dominique;Vernel-Pauillac, Frédérique;Boyer, Aurélie;Baron-Bodo, Véronique;Mallard, Eric;Bartholeyns, Jacques;Goxe, Béatrice;Latour, Nathalie;Leroy, Sophie;Prigent, Didier;Martiat, Philippe ;Sales, Francois;Laporte, Marianne;Bruyns, Catherine ;Romet-Lemonne, Jean-Loup;Abastado, Jean-Pierre;Lehmann, Frédéric ;Velu, Thierry
Référence Cancer immunology and immunotherapy, 55, 7, page (819-829)
Publication Publié, 2006-07
;Massicard, Séverine;Duriau, Dominique;Vernel-Pauillac, Frédérique;Boyer, Aurélie;Baron-Bodo, Véronique;Mallard, Eric;Bartholeyns, Jacques;Goxe, Béatrice;Latour, Nathalie;Leroy, Sophie;Prigent, Didier;Martiat, Philippe ;Sales, Francois;Laporte, Marianne;Bruyns, Catherine ;Romet-Lemonne, Jean-Loup;Abastado, Jean-Pierre;Lehmann, Frédéric ;Velu, Thierry Référence Cancer immunology and immunotherapy, 55, 7, page (819-829)
Publication Publié, 2006-07
Article révisé par les pairs
| Titre: |
|
| Auteur: | Salcedo, Margarita; Bercovici, Nadège; Taylor, Rachel; Vereecken, Pierre; Massicard, Séverine; Duriau, Dominique; Vernel-Pauillac, Frédérique; Boyer, Aurélie; Baron-Bodo, Véronique; Mallard, Eric; Bartholeyns, Jacques; Goxe, Béatrice; Latour, Nathalie; Leroy, Sophie; Prigent, Didier; Martiat, Philippe; Sales, Francois; Laporte, Marianne; Bruyns, Catherine; Romet-Lemonne, Jean-Loup; Abastado, Jean-Pierre; Lehmann, Frédéric; Velu, Thierry |
| Informations sur la publication: | Cancer immunology and immunotherapy, 55, 7, page (819-829) |
| Statut de publication: | Publié, 2006-07 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Allogeneic melanoma lysate |
| Dendritic cells Immunotherapy | |
| Human clinical trial | |
| T-cell responses | |
| MeSH keywords: | Adult |
| Aged | |
| Antigens, Neoplasm -- administration & dosage | |
| Antigens, Neoplasm -- therapeutic use | |
| Cancer Vaccines -- adverse effects | |
| Cancer Vaccines -- therapeutic use | |
| Cell Line, Tumor -- chemistry | |
| Cell Line, Tumor -- immunology | |
| Cells, Cultured -- drug effects | |
| Cells, Cultured -- immunology | |
| Cells, Cultured -- transplantation | |
| Culture Media, Serum-Free | |
| Dendritic Cells -- drug effects | |
| Dendritic Cells -- immunology | |
| Dendritic Cells -- transplantation | |
| Female | |
| Granulocyte-Macrophage Colony-Stimulating Factor -- pharmacology | |
| HLA-A2 Antigen -- immunology | |
| Hepatitis B Surface Antigens -- administration & dosage | |
| Humans | |
| Injections | |
| Injections, Intradermal | |
| Injections, Subcutaneous | |
| Interleukin-13 -- pharmacology | |
| Isoantigens -- administration & dosage | |
| Isoantigens -- therapeutic use | |
| Liver Neoplasms -- immunology | |
| Liver Neoplasms -- secondary | |
| Liver Neoplasms -- therapy | |
| Lung Neoplasms -- immunology | |
| Lung Neoplasms -- secondary | |
| Lung Neoplasms -- therapy | |
| Lymph Nodes | |
| Lymphatic Metastasis | |
| Male | |
| Melanoma -- immunology | |
| Melanoma -- secondary | |
| Melanoma -- therapy | |
| Middle Aged | |
| Skin Neoplasms -- immunology | |
| Skin Neoplasms -- therapy | |
| Tetanus Toxoid -- administration & dosage | |
| Tissue Extracts -- administration & dosage | |
| Tissue Extracts -- immunology | |
| Tissue Extracts -- therapeutic use | |
| Treatment Outcome | |
| Vaccination -- adverse effects | |
| Note générale: | Clinical Trial, Phase I |
| Clinical Trial, Phase II | |
| Journal Article | |
| Research Support, Non-U.S. Gov't | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0340-7004 |
| info:doi/10.1007/s00262-005-0078-6 | |
| info:scp/33645297917 | |
| info:pmid/16187085 |
